CyberKnife® Treatment for Prostate Cancer

The CyberKnife robotic radiosurgery system is a widely used form of nonsurgical prostate stereotactic body radiation therapy (SBRT). The American Society for Radiation Oncology (ASTRO) believes that enough clinical evidence exists so that SBRT should be considered an appropriate treatment option for select patients with low- to intermediate-risk prostate cancer. CyberKnife is designed to avoid healthy tissue and critical anatomy, therefore reducing side effects such as erectile dysfunction, urinary and bowel complications.

Key Advantages

  • Only 5 Treatments
  • Pinpoint Accuracy
  • Few Side Effects
  • Non-Invasive
  • No Recovery Time
VA Choice Program

Louisville CyberKnife is now accepting patients through the Veteran's Choice program. Click on the button below to see if you are a candidate.

Speak with one of our dedicated team members about how we can help today.

CyberKnife® Treatment for Prostate Cancer

The CyberKnife robotic radiosurgery system is a widely used form of nonsurgical prostate stereotactic body radiation therapy (SBRT). The American Society for Radiation Oncology (ASTRO) believes that enough clinical evidence exists so that SBRT should be considered an appropriate treatment option for select patients with low- to intermediate-risk prostate cancer. CyberKnife is designed to avoid healthy tissue and critical anatomy, therefore reducing side effects such as erectile dysfunction, urinary and bowel complications.

Key Advantages

  • Only 5 Treatments
  • Pinpoint Accuracy
  • Few Side Effects
  • Non-Invasive
  • No Recovery Time

Prostate Cancer Early Detection

The American Cancer Society (ACS) recommends that men have a chance to make an informed decision with their health care provider about whether to be screened for prostate cancer. The decision should be made after getting information about the uncertainties, risks, and potential benefits of prostate cancer screening. Men should not be screened unless they have received this information. Men who want to be screened should be tested with the prostate-specific antigen (PSA) blood test.

American Cancer Society
Recommended Prostate Cancer Screening Times

  • Age 50 for men who are at average risk of prostate cancer and are expected to live at least 10 more years.
  • Age 45 for men at high risk of developing prostate cancer. This includes African Americans and men who have a first-degree relative (father, brother, or son) diagnosed with prostate cancer at an early age (younger than age 65).
  • Age 40 for men at even higher risk (those with more than one first-degree relative who had prostate cancer at an early age).

Speak with one of our dedicated team members about how we can help today.

VA Choice Program

Louisville CyberKnife is now accepting patients through the Veteran's Choice program. Click on the button below to see if you are a candidate.